Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.
Wiggins JM, Zhang Q, Zhang Y, Vand-Rajabpour F, Hanniford D, He L, Lu Y, Kenney JM, Sadeghi KD, Argibay D, Orlow I, Busam KJ, Lezcano C, Lee TK, Luo L, Gorlov IP, Amos C, Ernstoff MS, Seshan VE, Cust AE, Wilmott J, Scolyer RA, Mann GJ, Reiner A, Kostrzewa CE, Nagore E, Funchain P, Ko J, Edmiston SN, Conway K, Googe PB, Ollila DW, Lee JE, Rees JR, Thompson CL, Gerstenblith M, Bosenberg M, Gould Rothberg BE, Osman I, Saenger Y, Reynolds AZ, Boyce T, Holmen S, Yan S, Brunsgaard E, Bogner P, Kuan PF, Thomas NE, Begg CB, Shen R, Berwick M, Shao Y, Polsky D, Hernando E.
Wiggins JM, et al. Among authors: gorlov ip.
Clin Cancer Res. 2025 Dec 15;31(24):5225-5236. doi: 10.1158/1078-0432.CCR-24-3785.
Clin Cancer Res. 2025.
PMID: 41114662
Free PMC article.